Iovance Biotherapeutics Inc (IOVA)
Cost of Revenue
$167.68M
TTM · Period ending: · USD
IOVA Cost of Revenue
Latest reported$167.68Mperiod ending
Latest reported$167.68Mperiod ending
IOVA Cost of Revenue ($0.00 → $167.68M)
Annual cost of revenue
High-resolution chart · PNG
IOVA cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 173,184,000 | |
| 123,995,000 | |
| 10,755,000 | |
| 0 | |
| 0 | |
| 0 | |
| 8,123,000 | |
| 956,000 | |
| 952,000 | |
| 978,000 | |
| 999,000 | |
| 88,221 | |
| 4,655,000 | |
| 6,477,000 | |
| 19,303,000 | |
| 0 | |
| 1,332 | |
| 0 |